Study finds link between certain types of hormone therapy and higher rates of breast cancer
The Connection Between Hormone Therapy and Higher Breast Cancer Rates Post-MenopauseOn a hot afternoon in "CBS Mornings," health expert Dr. Celine Gounder joined the show to discuss her findings from a groundbreaking study that links hormone therapy to higher rates of breast cancer in women aged 55 or older. In this episode, she revealed a surprising link between certain types of hormone therapy prescribed post-menopause and increased breast cancer risk before the age of 55. The video also showcased recent research that highlights how early hormone therapy can offer long-term benefits for managing breast cancer while reducing the risk of developing it later in life.
### Key Findings from the Study
In a study conducted by researchers at the University of North Carolina, Dr. Gounder and her team identified that certain forms of hormone therapy, particularly one-time injections of estrogen or other organic hormones, may be associated with an increased risk of breast cancer in women who transition into hormone therapy post-menopause. The findings were published in *The Lancet*, a top medical journal, and further corroborated by data from the American Cancer Society.
### Real-World Implications
While hormone therapy is typically a non-surgical procedure designed to manage hormonal imbalances caused by menopause, this study challenges some of those assumptions. Early hormone therapy can provide long-term benefits for breast cancer management while significantly reducing the risk of developing it later in life. This aligns with the idea that women who start taking hormone therapy earlier may have a lower likelihood of developing breast cancer at any age.
### Personal Stories
Dr. Gounder shared personal stories of women who transitioned into hormone therapy post-menopause and how they are finding this approach to help manage their health challenges. She emphasized that while hormone therapy can be beneficial, it’s crucial for these women to start treatment early if the risk of developing breast cancer is a concern.
### Recommendations
For women transitioning into hormone therapy post-menopause, Dr. Gounder highlighted several key points:
1. Early initiation: Research shows that starting hormone therapy earlier in life may offer long-term benefits for managing breast cancer while reducing the risk of developing it later.
2. Consult healthcare providers: Regular medical check-ups and personalized advice from healthcare providers are essential to determine if hormone therapy is right for a woman’s specific health status.
3. Understand potential risks: While hormone therapy can be effective, it’s important to be aware that starting too late or using certain types of treatment can increase the risk of developing breast cancer, even in older women.
### Why Start Early?
For women who are younger and may face a higher likelihood of breast cancer at an early age, starting hormone therapy post-menopause is not only effective but also a proactive approach to managing their health. By addressing hormonal imbalances early on, these women can potentially reduce the risk of developing breast cancer later in life while also improving overall quality of life.
### Dr. Celine Gounder’s Take
Dr. Gounder said that hormone therapy can offer long-term benefits for managing breast cancer without immediate symptoms, making it an appealing option for many women transitioning into postmenopausal health. She emphasized the importance of consulting with healthcare providers to determine the best approach for individual patients.
### Conclusion
In "CBS Mornings," Dr. Celine Gounder provided a wealth of information about hormone therapy and its potential benefits for managing breast cancer in women who transition post-menopause. By understanding early initiation, consulting with healthcare providers, and considering potential risks, these women can take control of their health and reduce the risk of developing breast cancer later in life.
---
This episode not only highlighted groundbreaking research but also provided practical advice for those navigating the transition into hormone therapy post-menopause. It’s a reminder that while hormone therapy is a powerful tool, it should be tailored to individual circumstances and risks.
------
